SEI INVESTMENTS CO - INTRA CELLULAR THERAPIES INC ownership

INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 142 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2020. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.

Quarter-by-quarter ownership
SEI INVESTMENTS CO ownership history of INTRA CELLULAR THERAPIES INC
ValueSharesWeighting
Q3 2023$7,180,283
-24.4%
137,841
-8.1%
0.01%
-23.5%
Q2 2023$9,500,638
+14.5%
150,042
-2.1%
0.02%
+13.3%
Q1 2023$8,298,882
+13.7%
153,258
+11.1%
0.02%
-6.2%
Q4 2022$7,297,851
+5.9%
137,903
-6.9%
0.02%
+6.7%
Q3 2022$6,889,000
-23.7%
148,046
-6.4%
0.02%
-25.0%
Q2 2022$9,033,000
-22.0%
158,247
-16.2%
0.02%
-13.0%
Q1 2022$11,576,000
+33.3%
188,920
+14.0%
0.02%
+43.8%
Q4 2021$8,683,000
+54.1%
165,649
+9.5%
0.02%
+33.3%
Q3 2021$5,636,000
+199.0%
151,324
+227.5%
0.01%
+200.0%
Q2 2021$1,885,000
+217.9%
46,209
+164.5%
0.00%
+300.0%
Q1 2021$593,000
+37.3%
17,471
+28.5%
0.00%0.0%
Q4 2020$432,000
-36.6%
13,598
-48.8%
0.00%
-50.0%
Q3 2020$681,000
+134.0%
26,533
+134.3%
0.00%
+100.0%
Q2 2020$291,000
+66.3%
11,322
-0.6%
0.00%0.0%
Q1 2020$175,000
+503.4%
11,385
+375.2%
0.00%
Q1 2019$29,000
-44.2%
2,3960.0%0.00%
Q4 2018$52,0000.0%2,3960.0%0.00%
Q3 2018$52,000
+23.8%
2,3960.0%0.00%
Q2 2018$42,000
-97.5%
2,396
-97.9%
0.00%
-100.0%
Q4 2016$1,690,000
-2.3%
112,000
-1.4%
0.01%
-11.1%
Q3 2016$1,730,000
-60.1%
113,548
+1.7%
0.01%
-65.4%
Q2 2016$4,333,000
+54.6%
111,612
+10.7%
0.03%
+52.9%
Q1 2016$2,803,000
-38.2%
100,814
+19.5%
0.02%
-39.3%
Q4 2015$4,539,00084,3890.03%
Other shareholders
INTRA CELLULAR THERAPIES INC shareholders Q1 2020
NameSharesValueWeighting ↓
Sarissa Capital Management LP 640,000$25,626,0006.33%
Redmile Group, LLC 1,322,592$52,957,0004.01%
SENZAR ASSET MANAGEMENT, LLC 556,224$22,271,209,0003.24%
RA Capital Management 314,349$12,587,0001.81%
WALL STREET ASSOCIATES 205,657$8,235,0001.58%
Parametrica Management Ltd 5,400$216,0001.36%
Rhenman & Partners Asset Management AB 165,000$6,607,0001.05%
EAM Investors, LLC 95,168$3,811,0000.60%
Rock Springs Capital Management LP 180,000$7,207,0000.58%
WASATCH ADVISORS LP 1,085,973$43,482,0000.58%
View complete list of INTRA CELLULAR THERAPIES INC shareholders